Connection

Oliver Cornely to Anti-Bacterial Agents

Back to Details
This is a "connection" page, showing publications Oliver Cornely has written about Anti-Bacterial Agents.
Oliver Cornely
Connection Strength
0.420
Anti-Bacterial Agents
  1. Surgical site infections: current management and role of new antibiotics. Curr Opin Infect Dis. 2019 10; 32(5):517-522.
    View in: PubMed
    Score: 0.168
  2. Extended-pulsed fidaxomicin versus vancomycin for Clostridium difficile infection in patients aged =60 years (EXTEND): analysis of cost-effectiveness. J Antimicrob Chemother. 2018 09 01; 73(9):2529-2539.
    View in: PubMed
    Score: 0.156
  3. Extended-pulsed fidaxomicin versus vancomycin for Clostridium difficile infection: EXTEND study subgroup analyses. Eur J Clin Microbiol Infect Dis. 2019 Jun; 38(6):1187-1194.
    View in: PubMed
    Score: 0.040
  4. Thirty-Day Readmissions in Hospitalized Patients Who Received Bezlotoxumab With Antibacterial Drug Treatment for Clostridium difficile Infection. Clin Infect Dis. 2017 10 01; 65(7):1218-1221.
    View in: PubMed
    Score: 0.037
  5. Combination Antimicrobial Therapy for Enterococcus faecalis Infective Endocarditis. Clin Infect Dis. 2019 08 16; 69(5):900.
    View in: PubMed
    Score: 0.010
  6. Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection. N Engl J Med. 2017 01 26; 376(4):305-317.
    View in: PubMed
    Score: 0.009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.